Cadila Healthcare informs about press release

17 Jul 2020 Evaluate

Cadila Healthcare has informed that it has enclosed a Press Release dated July 17, 2020 titled ‘Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico with Pegylated Interferon alpha-2b to treat novel Coronavirus’. The contents of the Press Release give full details. Bring the aforesaid news to the notice of the members of the exchange and investors’ at large.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

867.80 -16.20 (-1.83%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×